Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt flag Egypt · Delayed Price · Currency is EGP
4.480
-0.020 (-0.44%)
At close: Jun 4, 2025
97.36%
Market Cap 6.77B
Revenue (ttm) 3.18B
Net Income (ttm) 389.08M
Shares Out 1.50B
EPS (ttm) 0.26
PE Ratio 17.45
Forward PE 9.50
Dividend 0.07 (1.49%)
Ex-Dividend Date n/a
Volume 1,961,632
Average Volume 9,415,516
Open 4.500
Previous Close 4.500
Day's Range 4.460 - 4.520
52-Week Range 2.000 - 4.880
Beta 0.17
RSI 47.47
Earnings Date May 13, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol RMDA
Full Company Profile

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.

Financial Statements

News

There is no news available yet.